Skip to main content
CCSB logo

CCSB — Investor Relations & Filings

Ticker · 1762 ISIN · TW0001762003 TW Manufacturing
Open in API
Filings indexed 1,610 across all filing types
Latest filing 2019-11-14 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1762

About CCSB

www.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) with a history dating back to 1964. The company focuses on the research, development, and large-scale production of high-quality APIs, particularly in the therapeutic areas of oncology, antifungal treatments, and immunosuppressants. CCSB offers a broad service portfolio that includes cGMP-compliant contract manufacturing and toll manufacturing. By leveraging advanced chemical synthesis and biotechnology platforms, the company provides tailored solutions to global pharmaceutical partners. CCSB adheres to rigorous international quality standards and environmental, health, and safety protocols, ensuring the reliable supply of critical medicinal components for the global healthcare market.

Recent filings

Filing Released Lang Actions
108年第3季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific dates such as 108年09月30日 (which corresponds to the third quarter of 2019 in the ROC calendar). The presence of detailed financial statement data (assets, liabilities, equity) indicates this is a financial report rather than an announcement or certification. The document length is 4479 characters, which is relatively short but contains substantive financial data. The content corresponds to a quarterly or interim financial report rather than a full annual report, as it references the third quarter and includes comparative data for prior periods. There is no indication that this is an announcement of a report or a certification. Therefore, the document is best classified as an Interim / Quarterly Report (IR). 9M 2019
2019-11-14 Chinese
108年第3季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data specifically related to changes in equity, including items such as common stock capital, capital surplus, legal surplus reserve, special surplus reserve, undistributed earnings, retained earnings, and other equity items. The data is presented for the current period and the same period last year, indicating a comprehensive financial statement for a partial fiscal year (the first three quarters of the year). The document length is 3864 characters, which is relatively short but contains substantive financial data rather than just an announcement or a certification. The presence of detailed financial tables and period-specific data aligns with the characteristics of an Interim / Quarterly Report (IR). There is no indication that this is a full annual report (10-K) or just an announcement or certification. Therefore, the document is best classified as an Interim / Quarterly Report (IR). 9M 2019
2019-11-14 Chinese
108年第3季大陸投資
Regulatory Filings Classification · 95% confidence The document is a tabular disclosure of investment amounts and related financial data concerning investments in mainland China by a Taiwanese listed company. It includes details such as capital amounts, investment methods, cumulative investment funds, shareholding percentages, and investment gains or losses for a specific quarter (108th year, 3rd quarter). The document is short (1311 characters) and primarily provides investment data rather than a full financial report or narrative. It does not contain comprehensive financial statements or management discussion. It appears to be a regulatory disclosure related to investment activities, likely a routine regulatory filing to comply with investment reporting requirements. There is no indication that this is an annual or interim report, audit report, earnings release, or any other specific report type. Given the nature and length, and the absence of detailed financial statements or management commentary, the best fit is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory disclosures that do not fit other categories.
2019-11-14 Chinese
108年10月營業收入
Interim / Quarterly Report Classification · 85% confidence The document is a summarized revenue report for a company named 中化生 for the month of October in the year 民國108 (2019). It contains numerical data on net operating revenue for the current month, the same month last year, and cumulative figures for the year, along with percentage changes. The document is short (766 characters) and appears to be a periodic financial summary rather than a full financial report. It does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). It also does not fit other categories like earnings release or investor presentation. Given the nature of the data and the format, it best fits the category of Interim / Quarterly Report (IR), as it provides substantive financial data for a period shorter than a full fiscal year. Q3 2019
2019-11-08 Chinese
108年10月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 中化生, reporting on the status of fund loans and endorsement guarantees for the current and previous month, including cumulative amounts and limits. It contains no detailed financial statements or analysis, nor does it announce or attach a full report. The content is regulatory in nature, providing compliance information about financial guarantees and loans, but it is very short (602 characters) and does not constitute a full financial report or announcement of a report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2019-11-08 Chinese
108年10月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, senior management, and their related parties. It shows the number of shares held, changes in holdings, and classifications of shares for various insiders. There is no indication of financial statements, earnings data, or management discussion. The content is focused on insider share transactions and holdings disclosures. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades). The document length is sufficient and the content is substantive insider shareholding data, not just an announcement or summary. Therefore, the appropriate classification is DIRS.
2019-11-06 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.